OOIR: Observatory of International Research

Papers

(The TQCC of Statistical Methods in Medical Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Covariate adjustment in Bayesian adaptive randomized controlled trials	203
Time-varying coefficient additive hazards model with latent variables	120
Interval estimation in three-class receiver operating characteristic analysis: A fairly general approach based on the empirical likelihood	46
Exact interval estimation for the linear combination of binomial proportions	38
Confidence estimation based on data from independent studies	35
Equivalence tests for ratio of means in bioequivalence studies under crossover design	34
Implementing response-adaptive designs when responses are missing: Impute or ignore?	31
A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over time	27
A Bayesian beta-binomial piecewise growth mixture model for longitudinal overdispersed binomial data	27
Investigations of sharp bounds for causal effects under selection bias	26
Semiparametric copula method for semi-competing risks data subject to interval censoring and left truncation: Application to disability in elderly	21
Analysis of hospital readmissions with competing risks	21
Joint meta-analysis of two diagnostic tests accounting for within and between studies dependence	20
Omnibus test for restricted mean survival time based on influence function	20
Accounting for informative observation process in transition models of binary longitudinal outcome: Application to medical record data	19
Modeling and estimating a threshold effect: An application to improving cardiac surgery practices	19
Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint	17
A capture-recapture modeling framework emphasizing expert opinion in disease surveillance	17
On flexible inverse probability of treatment and intensity weighting: Informative censoring, variable selection, and weight trimming	16
Random survival forests with multivariate longitudinal endogenous covariates	15
Response-adaptive treatment randomization for multiple comparisons of treatments with recurrent event responses	14
Multiplicative versus additive modelling of causal effects using instrumental variables for survival outcomes – a comparison	14
A family of Bayesian prognostic and predictive covariate-adjusted response-adaptive randomization designs	14
Analyzing heterogeneity in biomarker discriminative performance through partial time-dependent receiver operating characteristic curve modeling	14
New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression models	13

Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network	13
Nonparametric analysis of doubly truncated and interval-censored data	13
Correlational analyses of biomarkers that are harmonized through a bridging study due to measurement errors	12
Generalised pairwise comparisons for trend: An extension to the win ratio and win odds for dose-response and prognostic variable analysis with arbitrary statements of outcome preference	12
A unified approach based on multidimensional scaling for calibration estimation in survey sampling with qualitative auxiliary information	11
Generalized Bayesian kernel machine regression	11
Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials	11
Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effect	11
Fitting joint models of longitudinal observations and time to event by sequential Bayesian updating	10
Covariate selection for optimizing balance with an innovative adaptive randomization approach	10
Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity	10
Evaluating prognostic biomarkers for survival outcomes subject to informative censoring	10
Smoothing Lexis diagrams using kernel functions: A contemporary approach	10
Familywise error rate control for block response-adaptive randomization	10
Quantification of the influence of risk factors with application to cardiovascular diseases in subjects with type 1 diabetes	10
Competing risks models with two time scales	9
A Bayesian genomic selection approach incorporating prior feature ordering and population structures with application to coronary artery disease	9
An iterative matrix uncertainty selector for high-dimensional generalized linear models with measurement errors	9
A simple and robust parametric shared frailty model for recurrent events with the competing risk of death: An application to the Carvedilol Prospective Randomized Cumulative Survival trial	9
Modeling the patient mix for risk-adjusted CUSUM charts	9
Penalized variable selection in multi-parameter regression survival modeling	9
A generalization of moderated statistics to data adaptive semiparametric estimation in high-dimensional biology	8
Sample size calculation for multi-arm parallel design with restricted mean survival time	8
Adaptive sample size re-estimation designs for a two-stage randomized trial with binary outcome	8
A competing risks regression model for the association between time-varying opioid exposure and risk of overdose	8
Testing for marginal covariate effect when the subgroup size induced by the covariate is informative	8
Adjusting for switches to multiple treatments: Should switches be handled separately or combined?	8
Model-based adaptive randomization procedures for heteroscedasticity of treatment responses	8
More efficient estimators of the area under the receiver operating characteristic curve in paired ranked set sampling	8
The analysis of COVID-19 in-hospital mortality: A competing risk approach or a cure model?	8
Change plane model averaging for subgroup identification	8
Modified Brier score for evaluating prediction accuracy for binary outcomes	8
The effect of estimating prevalences on the population-wise error rate	8
Complete effect decomposition for an arbitrary number of multiple ordered mediators with time-varying confounders: A method for generalized causal multi-mediation analysis	8
Review of sample size determination methods for the intraclass correlation coefficient in the one-way analysis of variance model	8
Hunting for protective drugs at the break of a pandemic: Causal inference from hospital data	8
A tight fit of the SIR dynamic epidemic model to daily cases of COVID-19 reported during the 2021–2022 Omicron surge in New York City: A novel approach	7
Cause-specific hazard Cox models with partly interval censoring – Penalized likelihood estimation using Gaussian quadrature	7
On recurrent-event win ratio	7
Regression analysis of multivariate recurrent event data allowing time-varying dependence with application to stroke registry data	7
CFO: Calibration-free odds design for phase I/II clinical trials	7
MISL: Multiple imputation by super learning	7
Fixed and random effect selections in generalized linear mixed models	7
Statistical methods for clinical trials interrupted by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic: A review	7
Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials	7
qTPI: A quasi-toxicity probability interval design for phase I trials with multiple-grade toxicities	7
Estimation and inference on the partial volume under the receiver operating characteristic surface	7
Test sensitivity in a prospective cancer screening program: A critique of a common proxy measure	7
BOIN-ETC: A Bayesian optimal interval design considering efficacy and toxicity to identify the optimal dose combinations	7
Space-time interactions in Bayesian disease mapping with recent tools: Making things easier for practitioners	7

A new framework for semi-Markovian parametric multi-state models with interval censoring	6
A Weibull mixture cure frailty model for high-dimensional covariates	6
Improved and computationally stable estimation of relative risk regression with one binary exposure	6
Time-dependent receiver operating characteristic curve estimator for correlated right-censored time-to-event data	6
Generalized fiducial inference for the restricted mean survival time	6
Sample sizes required to estimate the protective efficacy of a vaccine when there is an unequal allocation of individuals across the vaccine and placebo groups	6
Mid-quantile regression for discrete responses	6
Using short-term endpoints to improve interim decision making and trial duration in two-stage phase II trials with nested binary endpoints	6
Estimation in discrete time coarsened multivariate longitudinal models	6
A Bayesian latent class approach to causal inference with longitudinal data	6
Local linear approximation with Laplacian smoothing penalty and application in biology	6
Editorial	6
A generalized epidemiological model with dynamic and asymptomatic population	6
Using circulating tumor DNA as a novel biomarker of efficacy for dose-finding designs in oncology	6
Multiple imputation approaches for epoch-level accelerometer data in trials	6
Estimand-based inference in the presence of long-term survivors	6
Combining multiple biomarkers linearly to minimize the Euclidean distance of the closest point on the receiver operating characteristic surface to the perfection corner in trichotomous settings	6
Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviour	6
Interval estimation for the Youden index of a continuous diagnostic test with verification biased data	6
Comparison of statistical methods for the analysis of patient-reported outcomes in randomised controlled trials: A simulation study	6
Use of clinical tolerance limits for assessing agreement	6
Quantile outcome adaptive lasso: Covariate selection for inverse probability weighting estimator of quantile treatment effects	5
Factorial survival analysis for treatment effects under dependent censoring	5
Bivariate copula regression models for semi-competing risks	5
Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precision	5
Unbiased and robust analysis of co-localization in super-resolution images	5
Bayesian analysis of joint quantile regression for multi-response longitudinal data with application to primary biliary cirrhosis sequential cohort study	5
An objective Bayesian approach to estimation in multistage experiments	5
LASSO-type instrumental variable selection methods with an application to Mendelian randomization	5
Distribution-free control charts for mixed-type data based on rank of interpoint distances	5
Semiparametric generalized estimating equations for repeated measurements in cross-over designs	5
The “Why” behind including “Y” in your imputation model	5
Group lasso priors for Bayesian accelerated failure time models with left-truncated and interval-censored data	5
Health utility adjusted survival: A composite endpoint for clinical trial designs	5
Simulation extrapolation method for measurement error: A review	5
MEGH: A parametric class of general hazard models for clustered survival data	5
Group sequential analysis of marked point processes: Plasma donation trials	5
Unified approach to optimal estimation of mean and standard deviation from sample summaries	5
Adaptive enrichment trial designs using joint modelling of longitudinal and time-to-event data	5
Penalized estimation of general frailty Poisson models for recurrent count events	5
Heterogeneous treatment effect estimation for observational data using model-based forests	5
Variance partitioning in spatio-temporal disease mapping models	5
Additive hazards model with time-varying coefficients and imaging predictors	5
Covariate-adjusted inference for doubly adaptive biased coin design	4
Comparisons of various estimates of the I2 statistic for quantifying between-study heterogeneity in meta-analysis	4
Estimating dynamic treatment regimes for ordinal outcomes with household interference: Application in household smoking cessation	4
Jointly assessing multiple endpoints in pilot and feasibility studies	4
Graphical methods to illustrate the nature of the relation between a continuous variable and the outcome when using restricted cubic splines with a Cox proportional hazards model	4
Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis	4
Causal rule ensemble method for estimating heterogeneous treatment effect with consideration of prognostic effects	4
An overview of optimal designs under a given budget in cluster randomized trials with a binary outcome	4
Average treatment effect on the treated, under lack of positivity	4
A comparison of various aggregation functions in multi-criteria decision analysis for drug benefit–risk assessment	4
Efficient estimation of the marginal mean of recurrent events in randomized controlled trials	4
Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?	4
Biomarker-driven optimal designs for patient enrollment restriction	4
Extended excess hazard models for spatially dependent survival data	4
Divided-and-combined omnibus test for genetic association analysis with high-dimensional data	4
Data-driven clustering of infectious disease incidence into age groups	4
Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints	4
Measuring the individualization potential of treatment individualization rules: Application to rules built with a new parametric interaction model for parallel-group clinical trials	4
Diagnostic accuracy analysis for multiple raters using probit hierarchical model for ordinal ratings	4
Sample size determination for adaptive crossover trial in detecting gene-drug interactions	4
Simulating time-to-event data subject to competing risks and clustering: A review and synthesis	4
Efficient algorithms for survival data with multiple outcomes using the frailty model	4
Bivariate joint models for survival and change of cognitive function	4
Regularization approaches in clinical biostatistics: A review of methods and their applications	4